Center Star Asset Management, LLC Abb Vie Inc. Call Options Transaction History

Center Star Asset Management, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Jul 11, 2022	SELL	$137.62 - $174.96 $522,956 - $664,848	-3,800 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$131.98 - $163.75 $501,523 - $622,250	3,800 New	3,800 $570,000
Q3 2021 Nov 02, 2021	SELL	$106.4 - $120.78 $117,040 - $132,858	-1,100 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$105.21 - $117.21 $1.86 Million - $2.07 Million	-17,700 Reduced 94.15%	1,100 $126,000
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $1.38 Million - $1.85 Million	18,800 New	18,800 $271,000
Q1 2020 Apr 13, 2020	SELL	$64.5 - $97.79 $851,400 - $1.29 Million	-13,200 Closed	0 $0
Q4 2019 Jan 14, 2020	BUY	$72.13 - $90.25 $382,289 - $478,325	5,300 Added 67.09%	13,200 $118,000
Q3 2019 Oct 24, 2019	BUY	$62.98 - $75.72 $497,542 - $598,188	7,900 New	7,900 $97,000
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $185,136 - $217,896	-2,400 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$77.85 - $96.01 $988,694 - $1.22 Million	-12,700 Reduced 84.11%	2,400 $2,000
Q3 2018 Oct 15, 2018	BUY	$88.91 - $98.84 $1.34 Million - $1.49 Million	15,100 New	15,100 $30,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Center Star Asset Management, LLC with notifications on news.